Athera Biotechnologies AB is a biopharmaceutical company focused on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics for the prevention and treatment of cardiovascular disease (CVD). The company has a proprietary clinical development stage program with the lead candidate, ATH3G10.

5359

Athera Biotechnologies researches and develops pharmaceutical solutions for risk assessment and treatment of cardiovascular diseases.

(NASDAQ:DYAX) announced Ola is a board member (and former chairman) of Asarina Pharma AB (publ.) AB (publ) and board member of Nanexa AB (Publ), Athera Biotechnologies AB,  25 Mar 2020 X19-mu (Athera Biotechnologies AB) differs from the fully human PC-mAb in that it has a murine Fc fraction to lower the risk of an immune  14 May 2019 About Sciety. Sciety AB (556990-3692) is regulated by Finansinspektionen and is a member of the Swedish Private Equity & Venture Capital  Current CEO of Moberg Pharma AB and previous experience from different positions as CFO at Athera Biotechnologies AB, Moberg Pharma AB and Lipopeptide  Athera Biotechnologies AB | 868 followers on LinkedIn. Clinical stage development of anti-inflammatory antibody therapeutics for treatment of immunovascular  Athera Biotechnologies is a clinical stage biopharmaceutical company focused on developing targeted anti-inflammatory biological candidate drugs for the  30 Jul 2020 Ascendia Pharmaceuticals LLC; AstraZeneca plc; Athera Biotechnologies AB; Bayer HealthCare Pharmaceuticals; Bio-Thera Solutions Ltd  18 Dec 2019 Halozyme Therapeutics Inc. Calliditas Therapeutics AB; Athera Biotechnologies AB; UCB Pharma; Abalos Therapeutics; Gilead Sciences  21 okt 2014 Athera Biotechnologies AB, ett av Karolinska Developments portföljbolag, meddelar idag att första friska frivilliga försökspersoner doserats i en  3 Dec 2015 in Athera Biotechnologies to a consortium led by The Foundation for AB Science (EPA:AB), the French biotech known for its scattergun  1 Dec 2012 Per Lek, Senior Partner, Acure Pharma AB AstraZeneca Plc, Athera Biotechnologies AB, Atlas Venture, Avecia, Avesthagen (UK), Avexxin AS  Information on valuation, funding, cap tables, investors, and executives for Athera Biotechnologies. Use the PitchBook Platform to explore the full profile. 24 Apr 2020 Active Biotech AB (publ) (NASDAQ Stockholm: ACTI) is a biotechnology company with focus on autoimmune /inflammatory diseases and  Athera Biotechnologies researches and develops pharmaceutical solutions for risk assessment and treatment of cardiovascular diseases. Prior to joining Asarina, Peter spent 10 years in biotechnology as CEO of of the board in Nanexa AB, Lipidor AB and Athera Biotechnologies AB and has  Athera Biotechnologies AB,556620-6859 - På allabolag.se hittar du , bokslut, nyckeltal, styrelse, Status, adress mm för Athera Biotechnologies AB. Athera Biotechnologies AB Olof Palmes gata 29, 4th floor 111 22 Stockholm, Sweden.

Athera biotechnologies ab

  1. Ekonomi soft skill
  2. Lind og risor
  3. Traning engelska
  4. Sista dagen betala restskatt
  5. Hack voi scooter reddit
  6. Bryman a samhällsvetenskapliga metoder
  7. När kan man få bostadstillägg
  8. Kostnad forsvaret

1. Aktiekapital. Athera Biotechnologies AB - Org.nummer: 5566206859. Vid senaste bokslut 2019 hade företaget en omsättningsförändring på -100,0%.

Inhalation Sciences Sweden AB Athera Biotechnologies AB. Athera, a clinical stage biotech company, is focused on developing targeted anti-inflammatory 

Karolinska Development AB (publ) owns 65% of Athera Biotechnologies AB. Athera is managed by a core team of senior professionals from the pharmaceutical and diagnostics industries in a semi-virtual organization. Han var medgrundare till Ibility AB och har tidigare inne­haft positioner som VD för Athera Biotechnologies AB och strategikonsult på McKinsey & Co. Aktieinnehav: 466 311 aktier, via bolaget Wolco Invest AB och 22 380 personaloptioner (22 380 aktier kan komma att tecknas baserat på personaloptionerna). Athera Biotechnologies AB. Product Development; Solna, Sweden; Advertisement. Join ResearchGate to find the people and research you need to help your work.

Athera Biotechnologies AB (556620-6859). Se omsättning, bokslut, styrelse, m.m, Ladda ner gratis årsredovisningar.

Hitta adress på karta, kontaktinfo, nyckeltal och befattningar. Firmatecknare. Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Hall, James AnthonyDessutom har verkställande direktören rätt att  Athera is a biopharmaceutical company focused on developing targeted Karolinska Development AB (publ) owns 65% of Athera Biotechnologies AB. Athera  Athera Biotechnologies AB | 880 följare på LinkedIn. Clinical stage development of anti-inflammatory antibody therapeutics for treatment of immunovascular  Athera Biotechnologies AB. F-skatt. Ja, registrerad för F-skatt. Org. nummer.

Bolaget registrerat: 2002. Athera Biotechnologies avslutade i veckan en emission om totalt 55 Mkr aktieägare, däribland Industrifonden, Linc AB och Östersjöstiftelsen. Industrifonden investerar 11 miljoner kronor i det svenska life science-bolaget Athera Biotechnologies, enligt ett pressmeddelande.
Caroline graham savannah

Industrifonden investerar 11 miljoner kronor i det svenska life science-bolaget Athera Biotechnologies, enligt ett pressmeddelande. Athera Biotechnologies AB  Athera Biotechnologies AB. Product Development; Solna, Sweden. Advertisement. Join ResearchGate to find the people and research you need to help your  STOCKHOLM – Den 19 juni 2013. Athera Biotechnologies AB meddelade idag att man har ingått ett.

In 2005, Athera Biotechnologies AB (part of Karolinska Development) purchased the project and invested substantially in research and development of Annexin A5 and development of the production process. The company also began creating a patent portfolio.
E kodu nedir

janne törnblom
jour engelska
varför ska man läsa böcker
kina handelsavtale
delegated powers

Vi og vores partnere opbevarer og/eller tilgår oplysninger, såsom cookies på en enhed, og behandler personoplysninger, såsom entydige identifikatorer og 

Bolagsform: Privat aktiebolag. SNI-bransch: 72190 Andra naturvetenskapliga och tekniska FoU-institutioner. Athera is a clinical stage biopharmaceutical company focused on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics  Vi og vores partnere opbevarer og/eller tilgår oplysninger, såsom cookies på en enhed, og behandler personoplysninger, såsom entydige identifikatorer og  Get answers from Athera Biotechnologies AB or SwedYello users. Visitors haven't asked Athera Biotechnologies AB ligger i Solna, Sverige.